Method of treating lung cancer
AssigneeMacau University of Science and Technology
InventorsXiao Jun Yao, Lai Han Elaine Leung, Liang Liu, Xing Xing Fan, Chun Xie
Life of this patent
Estimating the term…
Abstract
One embodiment relates to a method of treating lung cancer by administering a compound of formula I to a patient. Another embodiment relates to a method of treating cancer with a KRAS mutation that includes administering to a patient the compound with the following formula I:
Claims20
A method of treating non-small cell lung cancer (NSCLC) in a patient, comprising:
- administering a therapeutically effective amount of a compound to the patient to treat the NSCLC,
- wherein the compound is represented by formula I
A method of treating lung adenocarcinoma in a patient in need of treatment of the lung adenocarcinoma, comprising:
- administering a therapeutically effective amount of a compound to the patient to treat the lung adenocarcinoma,
- wherein the compound is represented by formula I
A method of inhibiting progress of tumor growth in a patient with cancer, comprising:
- diagnosing the patient with the cancer when the presence of a mutation of Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) in cancer cells is detected;
- and
- administering a compound to the patient with the cancer to inhibit the progress of tumor growth,
- wherein the compound is represented by formula I
Dependencies are inferred from the claim text.